Multidrug Resistance in Leukaemia

References

• Biedler J. L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies. Cancer Res. 1970; 30: 1174–1181
   PubMed Web of Science ®Google Scholar
• Croop J. M., Raymond M., Haber D., Devault A., Arceci R. J., Gros P., Housman D. E. The three mouse multi-drug resistance (mdr) genes are expressed in a tissue specific manner in normal mouse tissues. Mol. and Cell Bid. 1989; 9: 1346–1350
   PubMed Web of Science ®Google Scholar
• Chen C-J., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M., Roninson I. B. Internal duplication and homology with bacterial transport proteins in the mdr-1 (P glycoprotein) gene from multidrug resistant human cells. Cell 1986; 47: 381–389
   PubMed Web of Science ®Google Scholar
• Shen D-W., Fojo A., Roninson I. B., Chin J. E., Soffir R., Pastan I., Gottesman M. M. Multidrug resistance of DNA mediated transformants is linked to transfer to the human mdr 1 gene. Mol. and Cell Bid. 1986; 6: 4039–4045
   PubMed Web of Science ®Google Scholar
• Ueda K., Cardrelli C., Gottesman M. M., Pastan I. Expression of a full length cDNA for the human mdr 1 gene confers resistance to colchicine, doxorubicin and vinblastine. Proc. Natl. Acad. Sci. (USA) 1987; 84: 3004–3008
   PubMed Web of Science ®Google Scholar
• Gerlach J. H., Endicott J. A., Juranka P., Henderson G., Sarangi F., Deuchars K. L., Ling V. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 1986; 324: 485–489
   PubMed Web of Science ®Google Scholar
• Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumour cells. Biochimica et Biophysica Acta 1973; 323: 466–83
   PubMed Web of Science ®Google Scholar
• Juliano R. I., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta 1976; 455: 152–162
   PubMed Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Slamon D. J., Poplack D. G., Gottesman M. M., Pastan I. Expression of a multidrug-resistance gene in human tumours and tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Hitchins R. N., Harman D. H., Davey R. A., Bell D. R. Identification of a multidrug resistance associated antigen (P glycoprotein) in normal human tissue. Eur. J. Cancer Clin. Oncol. 1988; 24: 449–454
   PubMedGoogle Scholar
• Bradley G., Juranka P. F., Ling V. Mechanisms of multidrug resistance. Biochimica et Biophysica Acta 1988; 948: 87–128
   PubMed Web of Science ®Google Scholar
• Choi K., Chang-jie C., Kriegler M., Roninson I. B. An altered pattern of cross resistance in multidrug resistant human cells results from spontaneous mutations in the mdr-1 (P glycoprotein) gene. Cell 1988; 53: 519–529
   PubMed Web of Science ®Google Scholar
• Beck W. T., Mueller T. J., Tanzer L. R. Altered surface membrane glycoproteins in vinca alkaloid resistant human leukaemic lymphoblasts. Cancer Res. 1979; 39: 2070–2076
   PubMed Web of Science ®Google Scholar
• Holmes J. A., Jacobs A., Carter G., Janowska-Wieczorek, Padua R. A. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia. Brit. J. Haem. 1989; 72: 40–44
   PubMed Web of Science ®Google Scholar
• Bhalla K., Hindenburg A., Taub R. N., Grant S. Isolation and characterisation of an anthracycline resistant human leukaemic cell line. Cancer Res. 1985; 45: 3657–3662
   PubMed Web of Science ®Google Scholar
• Goldstein L., Calski H., Fojo A., Willingham M., Lai S-L., Gazdar A., Pirker R., Green A., Crist W., Brodeur G., Lieber M., Cassman J., Gottesman M., Pastan I. Expression of a multidrug resistance gene in human cancers. J. N.C.I. 1989; 81: 116–124
   PubMed Web of Science ®Google Scholar
• Sato H., Priesler H. D., Gottesman M. Expression of the multidrug resistance gene (MDR) in the cells of patients with ANNL. Amer. Soc. Haem. Abstr. 1988; 805: 224a
   Google Scholar
• Ma D., Scurr R., Davey R., Machertich S., Harman D., Dowden G., Isbister J., Bell D. Detection of a multidrug resistant phenotype in acute non lymphoblastic leukaemia. Lancet 1987; i: 135–137
   Google Scholar
• Tsuruo T., Sugimoto, Hamada Y. H. Detection of multidrug resistance markers, P glycoprotein and mdr 1 RNA in human leukaemia cells. Jpn. J. Cancer Res. 1987; 78: 1415–1419
   PubMedGoogle Scholar
• Holmes J. A., Jacobs A., Carter G., Whittaker J. A., Padua R. A. Is the mdr-1 gene relevant in chronic lymphocytic leukaemia. Leukemia 1990, In Press
   PubMed Web of Science ®Google Scholar
• Mannervik B., Ah P., Guthenberg C., Jennson H., Tahir M. K., Warholm M., Jornvall H. Identification of three classes of cytosolic glutathione transferases common to several mammalian species: Correlation between structural data and enzymatic properties. Proc. Null. Acad. Scr. U.S.A. 1985; 82: 7202–7206
   PubMed Web of Science ®Google Scholar
• Ketterer B., Meyer D. J., Coles B., Taylor J. B., Pemble S. I. Antimutagenesis and Anticarcinogenesis Mechanisms, D. M. Shankel, P. E. Hartman, T. Kada, A. Hollaender. Plenum Press, New York 1986; 103–126
   Google Scholar
• Cowell I., Dixon K., Pemble S., Ketterer B., Taylor J. The structure of the human glutathione S transferase gene. Biochem. J. 1988; 255: 79–83
   PubMed Web of Science ®Google Scholar
• Guthenberg C., Akerfeldt K., Mannervik B. Purification of glutathione-S-transferase from human placenta. Acta Chem. Scand. Ser. B. 1979; 33: 595–596
   PubMedGoogle Scholar
• Iho D., Partridge C., Kurosky A., Awasthi Y. Human glutathione S transferases. Characterisation of the anionic forms from lung and placenta. Biochem. J. 1984; 221: 33–41
   PubMed Web of Science ®Google Scholar
• Singh S., Lcal T., Ansari G., Awasthi Y. Purification and characterisation of glutathione S transferase of the human kidney. Biochem. J. 1987; 246: 179–186
   PubMed Web of Science ®Google Scholar
• Tew K., Clapper M., Greenberg R., Weese J., Hoffman S., Smith T. Glutathione S transferases in human prostate. Biochem. Biophys. Acta 1987; 926: 8–15
   PubMed Web of Science ®Google Scholar
• Cowan K., Batist C., Tulpule, Sinha A. B., Myers C. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen induced resistance to xenobiotics in rats. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 9328–9332
   PubMed Web of Science ®Google Scholar
• Robson C., Alexander J., Harris A., Hickson I. Isolation and characterisation of a Chinese hamster ovary cell line resistant to bifunctional nitrogen mustard. Cancer Res. 1986; 46: 6290–6294
   PubMed Web of Science ®Google Scholar
• Moscow J., Cowan H. Multidrug Re. J. N.C.I. 1988; 80: 14–20
   PubMed Web of Science ®Google Scholar
• McQuaid S., McCann S., Daly P., Lawlor E., Humphries P. Observations on the transcriptional activity of the glutathione S transferase gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy. Brit. J. Cancer 1989; 59: 540–543
   PubMed Web of Science ®Google Scholar
• Isberg R., Syvanen M. DNA gyrase is a host factor required for transposition of Tn5. Cell 1982; 30: 9–18
   PubMed Web of Science ®Google Scholar
• Glisson B., Gupta R., Hodges P., Ross W. Cross resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. Cancer Res. 1986; 46: 1939–1942
   PubMed Web of Science ®Google Scholar
• Glisson B., Gupta R., Smallwood-Kentro S., Ross W. Characterisation of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug stimulated DNA cleavage activity. Cancer Res. 1986; 46: 1934–1938
   PubMed Web of Science ®Google Scholar
• Chow K-C., Ross W. Topoisomerase specific drug senstivity in relation to cell cycle progression. Mol. and Cell Biol. 1987; 7: 3119–3123
   PubMed Web of Science ®Google Scholar
• Deffie A., Batra, Goldenberg J. G. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamyciin sensitive and resistant P388 leukaemia cell lines. Cancer Res. 1989; 49: 56–62
   Google Scholar
• Potmesil M., Hsiang Y., Liu Bank L. B., Grossberg H., Kirschenbaum S., Forlenzar T., Penziner A., Kanganis D., Knowles D., Traganos F., Silber R. Resistance of human leukaemic and normal lymphocytes to drug induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res. 1988; 48: 3537–3543
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Tsukagoshi C., Sakurai Y. Increased accumulation of vincristine and adriamycin drug resistant P38:3 tumour cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982; 42: 4730–4733
   PubMed Web of Science ®Google Scholar
• Klohs W., Steinkampf R., Havlick M., Jackson R. Resistancse to anthracyclines in multidrug resistant P388 murine leukaemia cells: Reversal by calcium channel blockers and calmoduliin antagonists. Cancer Res. 1986; 46: 4352–4356
   PubMed Web of Science ®Google Scholar
• Cano-Gauci D., Riordan J. Action of calcium antagonists on multidrug resistant cells. Biochem. Pharmacol. 1987; 36: 2115–2123
   PubMed Web of Science ®Google Scholar
• Deuchars K., Ling V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Seminars in Oncology 1989; 16: 156–165
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Naganuma K., Tsukagoshi J., Sakurai Y. Promotion by verapamil of vincristine responsiveness in tumour cell lines inherently resistant to the drug. Cancer Res. 1983; 43: 808–813
   PubMed Web of Science ®Google Scholar
• Merry S., Kerr D., Flanigan P., Milroy R., Freshney R., Kaye S. Inherent adriamycin resistance in a murine tumour line I. Circumvention with verapamil and norverapamil. Br. J. Cancer 1987; 56: 185
   Web of Science ®Google Scholar
• Dalton W., Grogan T., Meltzer P., Scheper R., Durie B., Taylor C., Miller T., Salmon S. Drug resistance in multiple myeloma and non Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by the addition of verapamil to chemotherapy. J. Clin. Oncol. 1989; 7: 415–424
   PubMed Web of Science ®Google Scholar
• Skovsgaard T. Circumvention of resistance to daunomycin by N acetyl daunorubicin in Ehrlich ascites tumour. Cancer Res. 1980; 40: 1077–1083
   PubMed Web of Science ®Google Scholar
• Ramu A. D., Glaubiger Fuks Z. Reversal of acquired resistance to doxorubicin in P388 murine leukaemia cells by tamoxiferi and other triparanol analogues. Cancer Res. 1984; 44: 4392–4395
   PubMed Web of Science ®Google Scholar
• Twentyman P. Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins. Br. J. Cancer 1988; 57: 254–258
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Kitatani Y., Yokota K., Tsukagoshi S., Sakurai Y. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug resistant tumour cells. Cancer Res. 1984; 44: 4303–4307
   PubMed Web of Science ®Google Scholar
• Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 472–477
   PubMed Web of Science ®Google Scholar
• Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of (VAL-12) Ha ras transformed NIH 3T3 cells. Biochem. and Biophys. Res. Comm. 1988; 157: 183–189
   PubMed Web of Science ®Google Scholar
• Burt R., Garfield S., Johnson K., Thorgeirsson S. Transformation of rat liver epithelial cells with v-H ras or v raf causes expression of MDR-1, glutathione S transferase - P and increased resistance to cytotoxic chemicals. Carcinogenesis 1988; 9: 2329–2332
   PubMed Web of Science ®Google Scholar